November 19, 2024
1 min watch
Save
VIDEO: ONL1204 has different approach for treatment of geographic atrophy
CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses study results presented at the AAO meeting on ONL1204 from ONL Therapeutics.
“It’s a very different approach, really more of a neuroprotective approach for [geographic atrophy] and that I think is kind of exciting,” Miller said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Miller reports serving as a named inventor on patents and patent applications for ONL Therapeutics; serving as a consultant for ONL Therapeutics and Sumitomo Pharma Co.; serving in an advisory role for Drusolv Therapeutics; and receiving grant support from Lowy Medical Research Institute. Massachusetts Eye and Ear has a proprietary interest in photodynamic therapy and has received financial remuneration related to this technology. Miller reports receiving a share of the same in accordance with institutional guidelines.
Read more about